DIN 02514400 — ENHERTU 100 MG
ENHERTU is a powder for solution of Trastuzumab Deruxtecan marketed by ASTRAZENECA CANADA INC. The full Trastuzumab Deruxtecan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02514400
- Brand name
- ENHERTU
- Active ingredient
- Trastuzumab Deruxtecan
- Strength
- 100 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- HER2-directed antibody-drug conjugate (ADC) with a topoisomerase I inhibitor payload
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.